プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
octreotide użu għal ġol-muskoli n (%)
octreotide intramuscular use n (%)
最終更新: 2017-04-26
使用頻度: 1
品質:
octreotide (użat biex jittratta l-kanċer).
octreotide (used to treat cancer).
最終更新: 2017-04-26
使用頻度: 1
品質:
octreotide (użat għall-kura tal-kanċer)
octreotide (used to treat cancer)
最終更新: 2017-04-26
使用頻度: 2
品質:
somatostatin analogues bħal lanreotide u octreotide (użati biex jittrattaw akromegalija).
somatostatin analogues such as lanreotide and octreotide (used to treat acromegaly).
最終更新: 2017-04-26
使用頻度: 1
品質:
octreotide/lanreotide jistgħu jew iżidu jew inaqqsu l-ħtieġa tal-insulina.
octreotide/lanreotide may either increase or decrease the insulin requirement.
最終更新: 2017-04-26
使用頻度: 1
品質:
octreotide/lanreotide jistgħu jew iżidu jew inaqqsu l-ħtieġa għall-insulina.
octreotide/lanreotide may either increase or decrease the insulin requirement.
最終更新: 2017-04-26
使用頻度: 1
品質:
octreotide/ lanreotide t- tnejn jistgħu jżidu jew inaqqsu l- ħtiġijiet għall -
octreotide/ lanreotide may both decrease or increase insulin requirements.
最終更新: 2012-04-10
使用頻度: 2
品質:
octreotide/lanreotide jistgħu jew iżidu jew inaqqsu l-ħtieġa ta’ l-insulina.
octreotide/lanreotide may either increase or decrease the insulin requirement.
最終更新: 2017-04-26
使用頻度: 1
品質:
octreotide/lanreotide jistghu kemm inaqqsu kif ukoll izidu l-htiega ta’ l-insulina.
octreotide/lanreotide may both decrease and increase insulin requirement.
最終更新: 2017-04-26
使用頻度: 1
品質:
octreotide/ lanreotide jistg u kemm inaqqsu kif ukoll i idu l - tie a ta ’ l- insulina. tm
octreotide/ lanreotide may both decrease and increase insulin requirement. lo
最終更新: 2012-04-10
使用頻度: 2
品質:
octreotide/ lanreotide jistgħu t- tnejn iżidu jew inaqqsu l- ħtieġa ta ’ l- insulina.
octreotide/ lanreotide may both increase and decrease insulin requirement.
最終更新: 2012-04-10
使用頻度: 2
品質:
analogi ta’ somatostatin (bħal octreotide, jintużaw biex jikkuraw kundizzjoni mhux komuni fejn inti tipproduċi wisq ormon ta’ tkabbir),
omatostatin analogues (such as octreotide, used to treat an uncommon condition in which you make too much growth hormone),
最終更新: 2017-04-26
使用頻度: 1
品質:
id-doża inizjali kienet ta’ 40 mg għal pasireotide użu għal ġol-muskoli u ta’ 20 mg għal octreotide użu għal ġol-muskoli.
the starting dose was 40 mg for pasireotide intramuscular use and 20 mg for octreotide intramuscular use.
最終更新: 2017-04-26
使用頻度: 1
品質:
l-ogħla doża permessa kienet ta’ 60 mg għal pasireotide użu għal ġol-muskoli u ta’ 30 mg għal octreotide użu għal ġol-muskoli.
maximum allowed dose was 60 mg for pasireotide intramuscular use and 30 mg for octreotide intramuscular use.
最終更新: 2017-04-26
使用頻度: 1
品質:
il- ħtieġa tiegħek għall- insulina tista ’ tinbidel jekk inti tieħu wkoll: inibituri ta ’ monamine oxidase (maoi); beta- blokkanti; inibituri ta ’ l- enzima li tikkonverti l- anġjotensin (ace- inhibitors); acetylsalicylic acid; sterojdi anaboliċi; sulphonamides; kontraċettivi orali; tijażidi; glukokortikojdi; terapija bl- ormoni tat- tirojdi; beta- simpatomimetiċi; ormon tat- tkabbir; danazol; octreotide jew lanreotide.
your need for insulin may change if you also take: oral antidiabetic products; monoamine oxidase inhibitors (maoi); beta-blockers; ace-inhibitors; acetylsalicylic acid; anabolic steroids; sulphonamides; oral contraceptives; thiazides; glucocorticoids; thyroid hormone therapy; beta- sympathomimetics; growth hormone; danazol; octreotide or lanreotide.
最終更新: 2012-04-10
使用頻度: 9
品質: